Scientists prepare to test xenon gas as potential treatment for Alzheimer's disease

Scientists have found that inhaling xenon gas can activate brain immune cells to break down plaques related to Alzheimer's disease and reduce inflammation. Successful tests on mice have led to plans for human trials starting soon in Boston. Xenon, a colorless and odorless gas, has shown promise in treating Alzheimer's by penetrating the blood-brain barrier. In mouse models, it reduced brain atrophy and improved cognitive function, suggesting potential benefits for human patients. The upcoming clinical trial aims to explore xenon's effects on Alzheimer's in humans. If successful, it could lead to new treatment options for this common form of dementia, which currently has no cure.